$ 236.65
0.002882 BTC
0.88% (24h)
288,239 satoshies
Contract
ao
0xa1b...62b3ac
Info
Asset | 1h | 24h | 7d | 1m | 1y | max |
|---|---|---|---|---|---|---|
rasnd | - | - | - | - | - | - |
Ascendis Pharma A/S Tokenized Stock (Reality) Price Statistics
Market Cap Rank
#16703
Market Cap
496.539 $
Circulating Supply
2.098
Total Supply
-
Max Supply
-
Fully Diluted Valuation
-
24 Hour Trading Vol
498.1746 $
24h Low / 24h High
0/0
All-Time High
272.13
-13.03%
18 September, 2026, (a month ago)
All-Time Low
235.93
0.3%
18 September, 2026, (a month ago)
Ascendis Pharma A/S Tokenized Stock (Reality) Performance
Trading Pair
day
week
month
rasnd / usd
0%
0%
0%
rasnd / btc
0.88%
2.05%
-1.85%
rasnd / eth
0.9%
5.12%
7.06%
About Coin
Biopharmaceutical company utilizing TransCon technology to create long-acting therapies for rare diseases.
What is the highest value Ascendis Pharma A/S Tokenized Stock (Reality) (RASND) has ever reached?
Ascendis Pharma A/S Tokenized Stock (Reality) (RASND) reached its peak price at 272.13 $ on 18 September 2026, approximately a month ago. Presently, the current price is -13.03% lower than this all-time high.
What is the historical minimum price for Ascendis Pharma A/S Tokenized Stock (Reality) (RASND)?
The minimum price reached for Ascendis Pharma A/S Tokenized Stock (Reality) (RASND) was 235.93 $, documented on 18 September 2026, more than a month ago. In comparison, the current price is 0.3%, it above this historical low.
IMPORTANT DISCLAIMER: The information presented on our website and associated platforms is sourced from third parties and is intended for general informational purposes only. We do not guarantee the accuracy or timeliness of this content. None of the information provided should be construed as financial, legal, or other professional advice tailored to your specific needs. Your use of this content is at your own discretion and risk. It's important to independently research, evaluate, and verify the information before relying on it. Trading carries significant risks, so it's advisable to consult with a financial advisor before making any decisions. Our content is not intended to solicit or offer any services.
